Antibodies are referred as a Y-shaped glycoproteins produce by the adaptive immune system (B-cells) that bind specific antigens with high affinity and making them effective in the treatment of various types of diseases such as cancer, and inflammatory diseases. One of the major factors driving the growth of the antibody market is the increasing prevalence of various types of cancer among people worldwide. According to National Breast Cancer Foundation Inc., in 2025, it was estimated that approximately 316,950 women and 2,800 men diagnosed with invasive breast cancer, and an additional approximately 59,080 new cases of non-invasive breast cancer patients diagnose in the U.S. Whereas pharmaceutical companies are innovating new treatments for early detection and combat from the diseases.